| 351 | LUNGPulmonx Corp |
90,5 M US$ |
-59,7% |
2025 |
| 352 | VASOVASO Corp |
89,1 M US$ |
1,8% |
2025 |
| 353 | CBLLCeribell, Inc. |
89,1 M US$ |
-60,0% |
2025 |
| 354 | BDSXBiodesix Inc |
88,5 M US$ |
-39,8% |
2025 |
| 355 | CYTKCytokinetics Inc |
88 M US$ |
-891,6% |
2025 |
| 356 | DCTHDelcath Systems, Inc. |
85,2 M US$ |
3,2% |
2025 |
| 357 | FDMT4D Molecular Therapeutics, Inc. |
85,2 M US$ |
-164,4% |
2025 |
| 358 | SPRYARS Pharmaceuticals, Inc. |
84,3 M US$ |
-203,3% |
2025 |
| 359 | NRIXNurix Therapeutics, Inc. |
84 M US$ |
-314,9% |
2025 |
| 360 | IRMDIradimed Corp |
83,8 M US$ |
26,8% |
2025 |
| 361 | ARCTArcturus Therapeutics Holdings Inc. |
82 M US$ |
-80,2% |
2025 |
| 362 | FTLFFitlife Brands, Inc. |
81,5 M US$ |
7,8% |
2025 |
| 363 | MGTXMeiraGTx Holdings plc |
81,4 M US$ |
-140,3% |
2025 |
| 364 | ADCTADC Therapeutics SA |
81,4 M US$ |
-175,3% |
2025 |
| 365 | TELATELA Bio, Inc. |
80,3 M US$ |
-48,4% |
2025 |
| 366 | ETONEton Pharmaceuticals, Inc. |
80 M US$ |
-5,8% |
2025 |
| 367 | PDEXPro Dex Inc |
77,5 M US$ |
17,6% |
2026 |
| 368 | SGHTSight Sciences, Inc. |
77,4 M US$ |
-49,7% |
2025 |
| 369 | BNRBurning Rock Biotech Ltd |
77,2 M US$ |
-10,3% |
2025 |
| 370 | CTMXCytomX Therapeutics, Inc. |
76,2 M US$ |
-22,8% |
2025 |
| 371 | AUTLAutolus Therapeutics plc |
75,4 M US$ |
-381,4% |
2025 |
| 372 | ABCLAbCellera Biologics Inc. |
75,1 M US$ |
-194,9% |
2025 |
| 373 | RXRXRecursion Pharmaceuticals, Inc. |
74,7 M US$ |
-863,4% |
2025 |
| 374 | ELMDElectromed, Inc. |
73,8 M US$ |
15,3% |
2026 |
| 375 | CLLSCellectis S.A. |
72,9 M US$ |
-92,7% |
2025 |
| 376 | CGENCompugen Ltd |
72,8 M US$ |
48,6% |
2025 |
| 377 | BCYCBicycle Therapeutics PLC |
72,6 M US$ |
-301,7% |
2025 |
| 378 | ASMBAssembly Biosciences, Inc. |
72,3 M US$ |
-8,5% |
2025 |
| 379 | RCELAVITA Medical, Inc. |
71,6 M US$ |
-67,8% |
2025 |
| 380 | VRDNViridian Therapeutics, Inc. |
70,8 M US$ |
-483,6% |
2025 |
| 381 | FOCLEdap Tms SA |
70,5 M US$ |
-41,5% |
2025 |
| 382 | BDTXBlack Diamond Therapeutics, Inc. |
70 M US$ |
32,0% |
2025 |
| 383 | PSNLPersonalis, Inc. |
69,6 M US$ |
-116,7% |
2025 |
| 384 | RMTIRockwell Medical, Inc. |
69,3 M US$ |
-7,7% |
2025 |
| 385 | VIRVir Biotechnology, Inc. |
68,6 M US$ |
-638,9% |
2025 |
| 386 | NTLAIntellia Therapeutics, Inc. |
67,7 M US$ |
-609,9% |
2025 |
| 387 | KURAKura Oncology, Inc. |
67,5 M US$ |
-412,9% |
2025 |
| 388 | SPROSpero Therapeutics, Inc. |
66,8 M US$ |
12,8% |
2025 |
| 389 | XGNExagen Inc. |
66,6 M US$ |
-30,0% |
2025 |
| 390 | CCMConcord Medical Services Holdings Ltd |
65,9 M US$ |
-20,2% |
2025 |
| 391 | ENTAEnanta Pharmaceuticals Inc |
65,3 M US$ |
-125,4% |
2025 |
| 392 | COSMCosmos Health Inc. |
65,3 M US$ |
-29,3% |
2025 |
| 393 | FBIOFortress Biotech, Inc. |
63,3 M US$ |
10,8% |
2025 |
| 394 | NUVBNuvation Bio Inc. |
62,9 M US$ |
-325,3% |
2025 |
| 395 | TNGXTango Therapeutics, Inc. |
62,4 M US$ |
-162,9% |
2025 |
| 396 | DERMJourney Medical Corp |
61,9 M US$ |
-18,5% |
2025 |
| 397 | MHUAFMeihua International Medical Technologies Co., Ltd. |
61,8 M US$ |
11,0% |
2025 |
| 398 | TRIBTrinity Biotech PLC |
61,6 M US$ |
-51,6% |
2024 |
| 399 | CSBRChampions Oncology, Inc. |
59,4 M US$ |
-2,0% |
2026 |
| 400 | APTAlpha Pro Tech Ltd |
59,1 M US$ |
6,0% |
2025 |